Latest scientific publications

  • Prolonged Venous Transit Is Associated With Unfavorable Outcomes in Anterior Circulation Distal Medium Vessel Stroke.

  • Auteurs Salim HA, Lakhani DA, Balar A, Shahriari M, Sriwastawa A, Cho A, Dmytriw AA, Guenego A, Marsh EB, Lu H, Xu R, Leigh R, Shah G, Wen S, Albers GW, Hillis AE, Llinas R, Nael K, Wintermark M, Heit JJ, Faizy TD, Yedavalli VS
  • Revue J Neuroimaging
  • Date de publication 2025-01
Prolonged Venous Transit Is Associated With Unfavorable Outcomes in Anterior Circulation Distal Medium Vessel Stroke.
  • Tracking down the origin and subsequent spread of SARS-CoV-2 lineage B.1.619.

  • Auteurs Bollen N, Hong SL, Potter BI, Lienhard R, Tritten ML, Sierro N, Guedj E, Dulize R, Bornand D, Auberson M, Berthouzoz M, Duvoisin P, Ivanov NV, Peitsch MC, Hill V, Matheeussen V, Bontems S, Verhasselt B, Degosserie J, Waumans L, Bayon-Vicente G, Reynders M, Cattoir L, Coste V, Valgaeren H, Van Weyenbergh J, Cuypers L, André E, Durkin K, Maes P, Khan K, Huber C, Suchard MA, Maidadi Foudi M, Godwe C, Moumbeket Yifomnjou MH, Landry M, Njouom R, Mbala Kingebeni P, Oluniyi P, Olawoye IB, Happi C, Ayouba A, Peeters M, Behillil S, Simon-Lorière E, Hölzer M, Dellicour S, Dudas G, Baele G
  • Revue Virus Evol
  • Date de publication 2025-01
Tracking down the origin and subsequent spread of SARS-CoV-2 lineage B.1.619.
  • Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab Exposure.

  • Auteurs Cremer A, Mansour A, Lobaton T, Bossuyt P, Rahier J, Baert F, Dewit O, Macken E, Vijverman A, Van Hootegem P, Mana F, Willandt B, Humblet E, D'Heygere F, Verreth A, El Nawar A, Coenegrachts J, Dewit S, De Coninck S, Schoofs N, Delen S, Dutre J, Thienpont C, Vanden Branden S, Staessen D, Croonen C, Vieujean S, Franchimont D
  • Revue Acta Gastroenterol Belg
  • Date de publication 2025-01
Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab Exposure.
Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Erasme hospital

Erasme Hospital

View all of Erasme's scientific publications

Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital